Biocure Technology Inc. (CSE:CURE.X)
Canada · Delayed Price · Currency is CAD 0.0400
0.00 (0.00%)
At close: May 29, 2026
Biocure Technology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
808.28K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBiocure Technology News
- 25 days ago - Biocure Technology Inc. Announces Adoption of Semi-Annual Reporting - TheNewswire
- 1 year ago - CSE Bulletin: Consolidation - Biocure Technology Inc. (CURE.X) - Newsfile Corp
- 2 years ago - Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology - GlobeNewsWire
- 2 years ago - Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction - Newsfile Corp
- 4 years ago - Biocure Corporate Update - Newsfile Corp
- 4 years ago - Biocure Corporate Update and Financing - Newsfile Corp
- 5 years ago - Biocure Technology Inc. Announces Focus on its own CAR T-cell Therapy Targeting Chronic Lymphocytic Leukemia ("CLL") and Solid Tumor Cancers and Intent to Apply for Patents - Newsfile Corp
- 5 years ago - BioCure Technology Inc. Lists on the Frankfurt Stock Exchange and Completion of Issuer Sponsored Research Report - Newsfile Corp